Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "ether"

873 News Found

Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22
Healthcare | August 16, 2021

Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22

The hospital chain aggressively embarks on digitisation and is e-health ready


Apollo Hospitals inks MoU with Group of Hospitals for liver transplant
Healthcare | August 14, 2021

Apollo Hospitals inks MoU with Group of Hospitals for liver transplant

The MoU was signed on World Organ Donation Day which falls on August 13


India observes its first `Prediabetes Day' on August 14
Healthcare | August 14, 2021

India observes its first `Prediabetes Day' on August 14

Fitterfly has launched an online Prediabetes risk test which is an evidence-based, clinically validated tool for assessing an individual's risk of Prediabetes


Tesis Labs and Personal Genome Diagnostics tie-up to advance cancer treatment
Digitisation | August 11, 2021

Tesis Labs and Personal Genome Diagnostics tie-up to advance cancer treatment

The aim is to create new genomics solutions that could combat cancer and advance market access


Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
Biotech | August 10, 2021

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments


ALS drug RADICAVA holds promise as it completes four years in US
News | August 10, 2021

ALS drug RADICAVA holds promise as it completes four years in US

Nearly 6,000 patients have been treated with the drug since 2017


Fulgent Genetics and Helio Health partners to commercialize early cancer detection tests
Digitisation | August 10, 2021

Fulgent Genetics and Helio Health partners to commercialize early cancer detection tests

Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection


Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets
Drug Approval | August 09, 2021

Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets

Both companies aim to improve the efficiency and success rate of the current drug discovery process.


Stelis Biopharma appoints Mark W. Womack as CEO
People | August 07, 2021

Stelis Biopharma appoints Mark W. Womack as CEO

He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations


India’s gets its first bio-bank for heart failure research
Drug Approval | August 06, 2021

India’s gets its first bio-bank for heart failure research

Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology